SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 162 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $255,000 | -69.8% | 594,108 | +129.7% | 0.00% | -71.4% |
| Q1 2021 | $843,000 | -68.6% | 258,662 | -67.1% | 0.01% | -70.8% |
| Q4 2020 | $2,681,000 | -40.2% | 786,255 | -28.5% | 0.02% | -48.9% |
| Q3 2020 | $4,487,000 | +54.7% | 1,099,695 | +28.1% | 0.05% | +51.6% |
| Q2 2020 | $2,901,000 | +385.9% | 858,247 | +235.1% | 0.03% | +287.5% |
| Q1 2020 | $597,000 | -45.7% | 256,085 | -15.2% | 0.01% | -27.3% |
| Q4 2019 | $1,099,000 | +25.5% | 301,874 | +156.6% | 0.01% | -42.1% |
| Q2 2017 | $876,000 | -36.8% | 117,647 | -44.8% | 0.02% | -32.1% |
| Q1 2017 | $1,386,000 | +607.1% | 213,247 | +381.4% | 0.03% | +600.0% |
| Q4 2016 | $196,000 | -87.5% | 44,300 | -81.4% | 0.00% | -87.5% |
| Q2 2016 | $1,563,000 | +376.5% | 237,901 | +361.6% | 0.03% | +357.1% |
| Q1 2016 | $328,000 | +245.3% | 51,540 | +226.2% | 0.01% | +250.0% |
| Q4 2015 | $95,000 | +37.7% | 15,800 | +36.2% | 0.00% | +100.0% |
| Q3 2015 | $69,000 | -59.2% | 11,600 | -48.7% | 0.00% | -66.7% |
| Q2 2013 | $169,000 | – | 22,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |